;
Skip to main content
Home > BioCentury on BioBusiness > Analysts

Chronological Index of : Analyst Picks & Changes

 Current Issue
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/11 cls Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Barclays Capital Ying Huang Downgrade Underweight (from overweight) -77% $4.26 …

    Published on 10/14/2013
  • Analyst picks & changes

    Analyst picks & changes Wk 10/4 Company Bank Analyst Coverage Opinion chg cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Baird Brian Skorney Downgrade Neutral (from outperform) -62% $2.72 Deutsche …

    Published on 10/7/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/20 cls Celldex Therapeutics Inc. (NASDAQ:CLDX) Leerink Howard Liang Price target Outperform 24% $36.01 Liang raised his target to $…

    Published on 9/30/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/20 cls BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stifel Nicolaus Stephen Willey Downgrade Hold (from buy) 9% $76.95 Willey …

    Published on 9/23/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/13 cls Advanced Cell Technology Inc. (OTCBB:ACTC) Maxim Group Jason Kolbert New Buy 7% $0.06 Kolbert initiated coverage with a $0.…

    Published on 9/16/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/6 cls Pharmacyclics Inc. (NASDAQ:PCYC) Lazard Joshua Schimmer Upgrade Buy (from neutral) 6% $117.74 Schimmer also set a $141 target…

    Published on 9/9/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/30 cls Amgen Inc. (NASDAQ:AMGN) Piper Jaffray Ian Somaiya Upgrade Overweight (from neutral) 3% $108.94 Somaiya also raised his …

    Published on 9/2/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/16 cls Amarin Corp. plc (NASDAQ:AMRN) H.C. Wainwright Andrew Fein Upgrade Buy (from neutral) 11% $6 Fein also raised his target to…

    Published on 8/19/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/9 cls Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) MLV George Zavoico Downgrade Hold (from buy) 2% $20.76 Zavoico said 2Q13 was a "…

    Published on 8/12/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/2 cls Cubist Pharmaceuticals Inc. (NASDAQ:CBST) Credit Suisse Jason Kantor Upgrade Outperform (from neutral) 13% $63.10 Kantor also…

    Published on 8/5/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/26 cls Gilead Sciences Inc. (NASDAQ:GILD) Baird Brian Skorney Downgrade Neutral (from outperform) 4% $62.57 In his downgrade, …

    Published on 7/29/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/19 cls bluebird bio Inc. (NASDAQ:BLUE) JPMorgan Cory Kasimov New Overweight 11% $33.99 Wedbush David Nierengarten New Outperform…

    Published on 7/22/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/12 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Maxim Group Jason Kolbert Downgrade Hold (from buy) 12% $6.95 Kolbert also …

    Published on 7/15/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/28 cls Allergan Inc. (NYSE:AGN) Leerink Seamus Fernandez Downgrade Market perform (from outperform) -9% $84.24 Fernandez also …

    Published on 7/1/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/21 cls Elan Corp. plc (NYSE:ELN) Jefferies Corey Davis Price target Buy 2% $13.98 Davis raised his target from $14 to reflect his …

    Published on 6/24/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/14 cls Addex Therapeutics Ltd. (SIX:ADXN) Wedbush Christopher Marai Downgrade Neutral (from outperform) 18% CHF3.98 Marai also …

    Published on 6/17/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/7 cls Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) Leerink Joseph Schwartz Upgrade Outperform (from market perform) 7% $15.97 …

    Published on 6/10/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/31 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Canaccord Salveen Richter Price target Buy 21% $72.83 JPMorgan Cory Kasimov …

    Published on 6/3/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/24 cls Cubist Pharmaceuticals Inc. (NASDAQ:CBST) Jefferies Eun Yang Price target Buy 12% $55.49 RBC Capital Markets Adnan Butt …

    Published on 5/27/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/17 cls Actelion Ltd. (SIX:ATLN) UBS Guillaume van Renterghem Downgrade Neutral (from buy) -2% CHF58.80 Renterghem said Actelion's …

    Published on 5/20/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/10 cls Corcept Therapeutics Inc. (NASDAQ:CORT) Piper Jaffray Charles Duncan Downgrade Neutral (from overweight) -1% $1.75 Duncan …

    Published on 5/13/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/3 cls Amgen Inc. (NASDAQ:AMGN) Jefferies Eun Yang Other Buy -2% $106.48 Yang maintained her buy rating after issuing a note with …

    Published on 5/6/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/26 cls Amgen Inc. (NASDAQ:AMGN) Piper Jaffray Ian Somaiya Downgrade Neutral (from overweight) -3% $108.38 Somaiya downgraded based …

    Published on 4/29/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/12 cls Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) Ladenburg Thalmann Juan Sanchez Price target Buy 63% $12.54 MLV George Zavoico …

    Published on 4/15/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/5 cls Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) Piper Jaffray Charles Duncan Upgrade Overweight (from neutral) 3% $4.56 Duncan also…

    Published on 4/8/2013

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993